Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer

Gene Therapy

Volumn 4, Issue 10, 1997, Pages 1107-1114

  Degreve B ^a   Andrei, G ^a   Izquierdo, M ^b   Piette, J ^c   Morin, K ^d   Knaus, E E ^d   Wiebe, L I ^d   Basrah, I ^e   Walker, R T ^e   De Clercq, E ^a   Balzarini, J ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cancer; Gene therapy; Thymidine kinase; Varicella zoster virus

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXY 4' THIOURIDINE; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; 5 (2 IODOVINYL) 2' DEOXY 2' FLUORO 1 BETA D ARABINOFURANOSYLURACIL; ANTIVIRUS AGENT; DNA POLYMERASE; GANCICLOVIR; NUCLEOSIDE ANALOG; PHOSPHORYLASE; PYRIMIDINE NUCLEOSIDE; SORIVUDINE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CYTOSTASIS; DNA TRANSFECTION; DRUG STRUCTURE; ENZYME INHIBITION; GENE THERAPY; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS GENE;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 3; MAMMALIA; MURINAE;

EID: 0345814045     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300502     Document Type: Article

References (26)

1. Moolten FL. Drug sensitivity ('suicide') genes for selective cancer chemotherapy. Cancer Gene Ther 1994; 1: 279-287.
2. Mullen CA. Metabolic suicide genes in gene therapy. Pharmac Ther 1994; 63: 199-207.
3. Tiberghien P. Use of suicide genes in gene therapy. J Leukoc Biol 1994; 56: 203-209.
4. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
5. Miller N, Vile R. Targeted vectors for gene therapy. FASEB J 1995; 9: 190-199.
6. Vile RG. Tumor-specific gene expression. Semin Cancer Biol 1994; 5: 429-436.
7. Balzarini J, De Clercq E, Ayusawa D, Seno T. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2′-deoxyuridine and related compounds. FEBS Lett 1985; 185: 95-100.
8. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5281.
9. Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain rumors. Science 1992; 256: 1550-1552.
10. Oldfield EH et al. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993; 4: 39-69.
11. Raffel C et al. Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 1994; 5: 863-890.
12. Culver KW et al. Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 1994; 5: 343-379.
13. Kun LE et al. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Hum Gene Ther 1995; 6: 1231-1255.
14. Freeman SM et al. The treatment of ovarian cancer with a gene modified cancer vaccine: a phase I study. Hum Gene Ther 1995; 6: 927-939.
15. Balzarini J et al. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine derivatives for murine mammary (FM3A) carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene. Mol Pharmacol 1985; 28: 581-587.
16. Shimizu K et al. Establishment of mutant murine mammary carcinoma FM3A cell strains transformed with the herpes simplex virus type 2 thymidine kinase gene. Cell Struct Funct 1986; 11: 295-301.
17. Balzarini J, De Clercq E. Inhibitory effects of (E)-5-(2-bromovinyl)-2′-deoxyuridine and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells Meth Find Exp Clin Pharmacol 1989; 11: 379-389.
18. Balzarini J. Herpes simplex virus thymidine kinase gene-transfected tumor cells: sensitivity to antiherpetic drugs. Nucleosides Nucleotides 1996; 15: 821-831.
19. Huber BE, Richards CA, Krenitsky TA. Retrovirus-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci USA 1991; 88: 8039-8043
20. Shigeta S et al. Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus. J Infect Dis 1983; 147: 576-584.
21. Andrei G et al. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. Eur J Clin Microbiol Infect Dis 1995; 14: 318-328.
22. Balzarini J, De Clercq E. Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells. Biochim Biophys Acta 1984; 785: 36-45.
23. Santi DV. Perspectives on the design and biochemical pharmacology of inhibitors of thymidylate synthetase. J Med Chem 1980; 23: 103-111.
24. Balzarini J, Bohman C, Walker RT, De Clercq E. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected turner cells. Mol Pharmacol 1994; 45: 1253-1258-
25. Balzarini J et al. Novel (E)-5-(2-iodovinyl)-2′-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors. Gene Therapy 1995; 2: 317-322.
26. Balzarini J, Bohman C, De Clercq E. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2′-deoxyimdine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J Biol Chem 1993; 268: 6332-6337.